Erik Miljan

1.9k total citations
22 papers, 1.6k citations indexed

About

Erik Miljan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Developmental Neuroscience. According to data from OpenAlex, Erik Miljan has authored 22 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 6 papers in Developmental Neuroscience. Recurrent topics in Erik Miljan's work include Pluripotent Stem Cells Research (6 papers), Neurogenesis and neuroplasticity mechanisms (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Erik Miljan is often cited by papers focused on Pluripotent Stem Cells Research (6 papers), Neurogenesis and neuroplasticity mechanisms (6 papers) and Glycosylation and Glycoproteins Research (3 papers). Erik Miljan collaborates with scholars based in United Kingdom, United States and Poland. Erik Miljan's co-authors include E. Bremer, John D. Sinden, Sara Patel, Kenneth H. Pollock, Paul Stroemer, Lara Stevanato, Susan J. Hines, Andrew Hope, R. J. Donato and Sihem Aouabdi and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Brain Research.

In The Last Decade

Erik Miljan

22 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Miljan United Kingdom 18 1.1k 397 252 239 207 22 1.6k
Odile deLapeyrière France 25 1.3k 1.2× 612 1.5× 357 1.4× 322 1.3× 279 1.3× 38 2.5k
Carol Hicks United States 13 1.6k 1.5× 410 1.0× 358 1.4× 240 1.0× 277 1.3× 14 2.3k
Devin Chandler-Militello United States 16 1.3k 1.2× 486 1.2× 520 2.1× 105 0.4× 208 1.0× 22 1.9k
Gerald F. Reis United States 14 724 0.7× 474 1.2× 98 0.4× 169 0.7× 284 1.4× 28 1.6k
Lidia De Filippis Italy 22 849 0.8× 411 1.0× 487 1.9× 101 0.4× 142 0.7× 43 1.6k
Shuji Wakatsuki Japan 18 728 0.7× 496 1.2× 146 0.6× 105 0.4× 299 1.4× 39 1.4k
Saïd Akli United States 24 1.0k 1.0× 287 0.7× 98 0.4× 104 0.4× 238 1.1× 40 1.8k
Dara Kallop United States 13 1.2k 1.1× 278 0.7× 96 0.4× 81 0.3× 176 0.9× 13 2.1k
Tanuja T. Merianda United States 16 1.1k 1.1× 753 1.9× 243 1.0× 104 0.4× 334 1.6× 18 1.6k
Patrizia Casalbore Italy 21 632 0.6× 345 0.9× 248 1.0× 98 0.4× 85 0.4× 41 1.3k

Countries citing papers authored by Erik Miljan

Since Specialization
Citations

This map shows the geographic impact of Erik Miljan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Miljan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Miljan more than expected).

Fields of papers citing papers by Erik Miljan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Miljan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Miljan. The network helps show where Erik Miljan may publish in the future.

Co-authorship network of co-authors of Erik Miljan

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Miljan. A scholar is included among the top collaborators of Erik Miljan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Miljan. Erik Miljan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Volz, Katharina S., Erik Miljan, Amanda Khoo, & John P. Cooke. (2012). Development of pluripotent stem cells for vascular therapy. Vascular Pharmacology. 56(5-6). 288–296. 22 indexed citations
2.
Muir, Keith W., John D. Sinden, Erik Miljan, & Laurence Dunn. (2011). Intracranial Delivery of Stem Cells. Translational Stroke Research. 2(3). 266–271. 16 indexed citations
4.
Thomas, Robert J., Andrew Hope, Paul Hourd, et al.. (2009). Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line. Biotechnology Letters. 31(8). 1167–1172. 33 indexed citations
5.
Jiang, Caihui, Budd A. Tucker, Kim J, et al.. (2009). Growth kinetics and transplantation of human retinal progenitor cells. Experimental Eye Research. 89(3). 301–310. 58 indexed citations
6.
Stevanato, Lara, Randolph Corteling, Paul Stroemer, et al.. (2009). c-MycERTAM transgene silencing in a genetically modified human neural stem cell line implanted into MCAo rodent brain. BMC Neuroscience. 10(1). 86–86. 28 indexed citations
7.
Miljan, Erik & John D. Sinden. (2009). Stem cell treatment of ischemic brain injury.. PubMed. 11(4). 394–403. 35 indexed citations
8.
Jiang, Caihui, Stephen Redenti, Henry Klassen, et al.. (2009). Molecular Characterization of Human Retinal Progenitor Cells. Investigative Ophthalmology & Visual Science. 50(12). 5901–5901. 52 indexed citations
9.
Miljan, Erik, Susan J. Hines, Randolph Corteling, et al.. (2008). Implantation of c-mycER TAM Immortalized Human Mesencephalic-Derived Clonal Cell Lines Ameliorates Behavior Dysfunction in a Rat Model of Parkinson’s Disease. Stem Cells and Development. 18(2). 307–320. 19 indexed citations
10.
Wood‐Kaczmar, Alison, Sonia Gandhi, Zhi Yao, et al.. (2008). PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons. PLoS ONE. 3(6). e2455–e2455. 258 indexed citations
11.
Wood‐Kaczmar, Alison, Sonia Gandhi, Zhi Yao, et al.. (2008). Correction: PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons. PLoS ONE. 3(7). 15 indexed citations
12.
Wood‐Kaczmar, Alison, Sonia Gandhi, Zhi Yao, et al.. (2008). Correction: PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons. PLoS ONE. 3(8). 12 indexed citations
13.
Donato, R. J., Erik Miljan, Susan J. Hines, et al.. (2007). Differential development of neuronal physiological responsiveness in two human neural stem cell lines. BMC Neuroscience. 8(1). 36–36. 233 indexed citations
14.
Pollock, Kenneth H., Paul Stroemer, Sara Patel, et al.. (2006). A conditionally immortal clonal stem cell line from human cortical neuroepithelium for the treatment of ischemic stroke. Experimental Neurology. 199(1). 143–155. 215 indexed citations
15.
Hoffrogge, Raimund, Stefan Mikkat, Christian Scharf, et al.. (2006). 2‐DE proteome analysis of a proliferating and differentiating human neuronal stem cell line (ReNcell VM). PROTEOMICS. 6(6). 1833–1847. 108 indexed citations
16.
Zacharias, William J., et al.. (2004). Tbx5 and Tbx4 transcription factors interact with a new chicken PDZ-LIM protein in limb and heart development. Developmental Biology. 273(1). 106–120. 63 indexed citations
17.
18.
Miljan, Erik, Emmanuelle J. Meuillet, Barbara Mania‐Farnell, et al.. (2002). Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides. Journal of Biological Chemistry. 277(12). 10108–10113. 147 indexed citations
19.
Miljan, Erik & E. Bremer. (2002). Regulation of Growth Factor Receptors by Gangliosides. Science s STKE. 2002(160). re15–re15. 132 indexed citations
20.
Miljan, Erik & E. Bremer. (2002). Regulation of Growth Factor Receptors by Gangliosides. Science Signaling. 2002(160). re15–re15. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026